Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy:
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen ; Nürnberg
Friedrich-Alexander-Universität Erlangen-Nürnberg
2014
|
| Schlagworte: | |
| Online-Zugang: | kostenfrei kostenfrei kostenfrei |
| Beschreibung: | Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. |
| Beschreibung: | 1 Online-Ressource |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045515035 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190318s2014 gw |||| o||u| ||||||eng d | ||
| 015 | |a 19,O04 |2 dnb | ||
| 016 | 7 | |a 1180028457 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-106011 |2 urn | |
| 035 | |a (OCoLC)1090781259 | ||
| 035 | |a (DE-599)DNB1180028457 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Ruilope, Luis M. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy |c Luis M. Ruilope, Rajiv Agarwal, Juliana C. Chan, Mark E. Cooper, Ron T. Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E. Schmieder, Christina Nowack, Anna C. Ferreira, Alexander Pieper, Nina Kimmeskamp-Kirschbaum, George L. Bakris |
| 264 | 1 | |a Erlangen ; Nürnberg |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2014 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 653 | |a Antagonist | ||
| 653 | |a Diabetic nephropathy | ||
| 653 | |a Heart failure | ||
| 653 | |a Mineralocorticoid receptor | ||
| 653 | |a Type 2 diabetes mellitus | ||
| 700 | 1 | |a Agarwal, Rajiv |e Verfasser |4 aut | |
| 700 | 1 | |a Chan, Juliana C. |e Verfasser |4 aut | |
| 700 | 1 | |a Cooper, Mark E. |e Verfasser |4 aut | |
| 700 | 1 | |a Gansevoort, Ron T. |e Verfasser |4 aut | |
| 700 | 1 | |a Haller, Hermann |e Verfasser |4 aut | |
| 700 | 1 | |a Remuzzi, Giuseppe |e Verfasser |4 aut | |
| 700 | 1 | |a Rossing, Peter |e Verfasser |4 aut | |
| 700 | 1 | |a Schmieder, Roland E. |e Verfasser |4 aut | |
| 700 | 1 | |a Nowack, Christina |e Verfasser |4 aut | |
| 700 | 1 | |a Ferreira, Anna C. |e Verfasser |4 aut | |
| 700 | 1 | |a Pieper, Alexander |e Verfasser |4 aut | |
| 700 | 1 | |a Kimmeskamp-Kirschbaum, Nina |e Verfasser |4 aut | |
| 700 | 1 | |a Bakris, George L. |e Verfasser |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t American Journal of Nephrology |g 40 (2014), Seite 572 - 581 |o 10.1159/000371497 |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-106011 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://d-nb.info/1180028457/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/10601 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030899451 | ||
| 347 | |b PDF | ||
Datensatz im Suchindex
| _version_ | 1804179461782896640 |
|---|---|
| any_adam_object | |
| author | Ruilope, Luis M. Agarwal, Rajiv Chan, Juliana C. Cooper, Mark E. Gansevoort, Ron T. Haller, Hermann Remuzzi, Giuseppe Rossing, Peter Schmieder, Roland E. Nowack, Christina Ferreira, Anna C. Pieper, Alexander Kimmeskamp-Kirschbaum, Nina Bakris, George L. |
| author_facet | Ruilope, Luis M. Agarwal, Rajiv Chan, Juliana C. Cooper, Mark E. Gansevoort, Ron T. Haller, Hermann Remuzzi, Giuseppe Rossing, Peter Schmieder, Roland E. Nowack, Christina Ferreira, Anna C. Pieper, Alexander Kimmeskamp-Kirschbaum, Nina Bakris, George L. |
| author_role | aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
| author_sort | Ruilope, Luis M. |
| author_variant | l m r lm lmr r a ra j c c jc jcc m e c me mec r t g rt rtg h h hh g r gr p r pr r e s re res c n cn a c f ac acf a p ap n k k nkk g l b gl glb |
| building | Verbundindex |
| bvnumber | BV045515035 |
| collection | ebook |
| ctrlnum | (OCoLC)1090781259 (DE-599)DNB1180028457 |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02832nmm a2200613zc 4500</leader><controlfield tag="001">BV045515035</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190318s2014 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">19,O04</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1180028457</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-106011</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1090781259</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1180028457</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ruilope, Luis M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy</subfield><subfield code="c">Luis M. Ruilope, Rajiv Agarwal, Juliana C. Chan, Mark E. Cooper, Ron T. Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E. Schmieder, Christina Nowack, Anna C. Ferreira, Alexander Pieper, Nina Kimmeskamp-Kirschbaum, George L. Bakris</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Antagonist</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Diabetic nephropathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Heart failure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mineralocorticoid receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Type 2 diabetes mellitus</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Agarwal, Rajiv</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chan, Juliana C.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cooper, Mark E.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gansevoort, Ron T.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Haller, Hermann</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Remuzzi, Giuseppe</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rossing, Peter</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schmieder, Roland E.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nowack, Christina</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferreira, Anna C.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pieper, Alexander</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kimmeskamp-Kirschbaum, Nina</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bakris, George L.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">American Journal of Nephrology</subfield><subfield code="g">40 (2014), Seite 572 - 581</subfield><subfield code="o">10.1159/000371497</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-106011</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1180028457/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/10601</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030899451</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="b">PDF</subfield></datafield></record></collection> |
| id | DE-604.BV045515035 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:20:14Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030899451 |
| oclc_num | 1090781259 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2014 |
| publishDateSearch | 2014 |
| publishDateSort | 2014 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| record_format | marc |
| spelling | Ruilope, Luis M. Verfasser aut Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy Luis M. Ruilope, Rajiv Agarwal, Juliana C. Chan, Mark E. Cooper, Ron T. Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E. Schmieder, Christina Nowack, Anna C. Ferreira, Alexander Pieper, Nina Kimmeskamp-Kirschbaum, George L. Bakris Erlangen ; Nürnberg Friedrich-Alexander-Universität Erlangen-Nürnberg 2014 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager Antagonist Diabetic nephropathy Heart failure Mineralocorticoid receptor Type 2 diabetes mellitus Agarwal, Rajiv Verfasser aut Chan, Juliana C. Verfasser aut Cooper, Mark E. Verfasser aut Gansevoort, Ron T. Verfasser aut Haller, Hermann Verfasser aut Remuzzi, Giuseppe Verfasser aut Rossing, Peter Verfasser aut Schmieder, Roland E. Verfasser aut Nowack, Christina Verfasser aut Ferreira, Anna C. Verfasser aut Pieper, Alexander Verfasser aut Kimmeskamp-Kirschbaum, Nina Verfasser aut Bakris, George L. Verfasser aut Sonderdruck aus American Journal of Nephrology 40 (2014), Seite 572 - 581 10.1159/000371497 https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-106011 Resolving-System kostenfrei Volltext http://d-nb.info/1180028457/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/10601 Verlag kostenfrei Volltext |
| spellingShingle | Ruilope, Luis M. Agarwal, Rajiv Chan, Juliana C. Cooper, Mark E. Gansevoort, Ron T. Haller, Hermann Remuzzi, Giuseppe Rossing, Peter Schmieder, Roland E. Nowack, Christina Ferreira, Anna C. Pieper, Alexander Kimmeskamp-Kirschbaum, Nina Bakris, George L. Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy |
| title | Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy |
| title_auth | Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy |
| title_exact_search | Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy |
| title_full | Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy Luis M. Ruilope, Rajiv Agarwal, Juliana C. Chan, Mark E. Cooper, Ron T. Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E. Schmieder, Christina Nowack, Anna C. Ferreira, Alexander Pieper, Nina Kimmeskamp-Kirschbaum, George L. Bakris |
| title_fullStr | Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy Luis M. Ruilope, Rajiv Agarwal, Juliana C. Chan, Mark E. Cooper, Ron T. Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E. Schmieder, Christina Nowack, Anna C. Ferreira, Alexander Pieper, Nina Kimmeskamp-Kirschbaum, George L. Bakris |
| title_full_unstemmed | Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy Luis M. Ruilope, Rajiv Agarwal, Juliana C. Chan, Mark E. Cooper, Ron T. Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E. Schmieder, Christina Nowack, Anna C. Ferreira, Alexander Pieper, Nina Kimmeskamp-Kirschbaum, George L. Bakris |
| title_short | Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy |
| title_sort | rationale design and baseline characteristics of arts dn a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-106011 http://d-nb.info/1180028457/34 https://open.fau.de/handle/openfau/10601 |
| work_keys_str_mv | AT ruilopeluism rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT agarwalrajiv rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT chanjulianac rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT coopermarke rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT gansevoortront rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT hallerhermann rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT remuzzigiuseppe rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT rossingpeter rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT schmiederrolande rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT nowackchristina rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT ferreiraannac rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT pieperalexander rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT kimmeskampkirschbaumnina rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy AT bakrisgeorgel rationaledesignandbaselinecharacteristicsofartsdnarandomizedstudytoassessthesafetyandefficacyoffinerenoneinpatientswithtype2diabetesmellitusandaclinicaldiagnosisofdiabeticnephropathy |